207 related articles for article (PubMed ID: 1707567)
1. The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes.
Christensen ND; Kreider JW; Kan NC; DiAngelo SL
Virology; 1991 Apr; 181(2):572-9. PubMed ID: 1707567
[TBL] [Abstract][Full Text] [Related]
2. Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the 'common antigen' region.
Strike DG; Bonnez W; Rose RC; Reichman RC
J Gen Virol; 1989 Mar; 70 ( Pt 3)():543-55. PubMed ID: 2471790
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of CRPV infectivity by monoclonal antibodies that identify conformational epitopes on intact virions.
Christensen ND; Kreider JW
Virus Res; 1991 Nov; 21(3):169-79. PubMed ID: 1722596
[TBL] [Abstract][Full Text] [Related]
4. Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus.
Lin YL; Borenstein LA; Selvakumar R; Ahmed R; Wettstein FO
Virology; 1992 Apr; 187(2):612-9. PubMed ID: 1312271
[TBL] [Abstract][Full Text] [Related]
5. Induction of neutralizing antibodies to papillomaviruses by anti-idiotypic antibodies.
Christensen ND; Reed CA; Cladel NM
Virology; 1995 Jul; 210(2):292-301. PubMed ID: 7542415
[TBL] [Abstract][Full Text] [Related]
6. Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins.
Christensen ND; Kreider JW; Cladel NM; Galloway DA
Virology; 1990 Mar; 175(1):1-9. PubMed ID: 2155503
[TBL] [Abstract][Full Text] [Related]
7. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
8. Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles.
Xu Y; Wang Q; Han Y; Song G; Xu X
J Med Microbiol; 2007 Jul; 56(Pt 7):907-913. PubMed ID: 17577054
[TBL] [Abstract][Full Text] [Related]
9. Type-specific and cross-reactive epitopes in human papillomavirus type 16 capsid proteins.
Beiss BK; Heimer E; Felix A; Burk RD; Ritter DB; Mallon RG; Kadish AS
Virology; 1991 Sep; 184(1):460-4. PubMed ID: 1714667
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
11. Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.
Gambhira R; Jagu S; Karanam B; Gravitt PE; Culp TD; Christensen ND; Roden RB
J Virol; 2007 Nov; 81(21):11585-92. PubMed ID: 17715230
[TBL] [Abstract][Full Text] [Related]
12. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.
Breitburd F; Kirnbauer R; Hubbert NL; Nonnenmacher B; Trin-Dinh-Desmarquet C; Orth G; Schiller JT; Lowy DR
J Virol; 1995 Jun; 69(6):3959-63. PubMed ID: 7745754
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody neutralization of BPV-1.
Christensen ND; Kreider JW
Virus Res; 1993 May; 28(2):195-202. PubMed ID: 7686316
[TBL] [Abstract][Full Text] [Related]
14. Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles.
Rose RC; Bonnez W; Strike DG; Reichman RC
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2725-9. PubMed ID: 2174962
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated neutralization in vivo of infectious papillomaviruses.
Christensen ND; Kreider JW
J Virol; 1990 Jul; 64(7):3151-6. PubMed ID: 1693698
[TBL] [Abstract][Full Text] [Related]
16. Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.
Pastrana DV; Gambhira R; Buck CB; Pang YY; Thompson CD; Culp TD; Christensen ND; Lowy DR; Schiller JT; Roden RB
Virology; 2005 Jul; 337(2):365-72. PubMed ID: 15885736
[TBL] [Abstract][Full Text] [Related]
17. Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes.
Palmer KE; Benko A; Doucette SA; Cameron TI; Foster T; Hanley KM; McCormick AA; McCulloch M; Pogue GP; Smith ML; Christensen ND
Vaccine; 2006 Jun; 24(26):5516-25. PubMed ID: 16725236
[TBL] [Abstract][Full Text] [Related]
18. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
Kirnbauer R; Booy F; Cheng N; Lowy DR; Schiller JT
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12180-4. PubMed ID: 1334560
[TBL] [Abstract][Full Text] [Related]
19. Protective cell-mediated immunity by DNA vaccination against Papillomavirus L1 capsid protein in the Cottontail Rabbit Papillomavirus model.
Hu J; Cladel NM; Budgeon LR; Reed CA; Pickel MD; Christensen ND
Viral Immunol; 2006; 19(3):492-507. PubMed ID: 16987067
[TBL] [Abstract][Full Text] [Related]
20. Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus.
Christensen ND; Reed CA; Cladel NM; Han R; Kreider JW
J Virol; 1996 Feb; 70(2):960-5. PubMed ID: 8551636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
